Protein Sorting and Vesicular Transport Flashcards

Endoplasmic Reticulum (ER) Protein Targeting and Synthesis

  • ER Co-translational Translocation

    • Proteins destined for the ER are generally transported across the membrane while they are still being synthesized (co-translational translocation).

    • These proteins possess an N-terminal signal sequence which facilitates the docking of the synthesizing ribosome onto the ER.

    • The entry of the protein across the ER membrane occurs simultaneously as the polypeptide chain is synthesized.

  • RNA and Protein Expression in the Rough ER

    • The rough ER consists of ER membranes and polyribosomes.

    • RNAs isolated from the rough ER encode for:

      • Soluble secreted proteins.

      • ER membrane proteins.

      • Plasma membrane proteins.

      • Proteins destined for the lysosome or Golgi apparatus.

  • Cytosolic Protein Synthesis

    • Ribosomal proteins are translated in the cytosol by cytosolic ribosomes, as they are cytoplasmic components.

  • Experimental Manipulation of ER Signal Sequences

    • Addition to Cytosolic Protein: Adding an ER signal sequence to the N-terminal of a normally cytosolic protein will cause it to be transported into the ER lumen.

    • Charge Alteration: Changing hydrophobic amino acids in an ER signal sequence to charged amino acids prevents recognition, causing the protein to remain in the cytosol.

    • Sequence Variation: Replacing hydrophobic amino acids with different hydrophobic amino acids still allows for ER delivery. The physical distribution of hydrophobicity is the critical factor, not the specific sequence of amino acids.

    • C-terminal Relocation: Moving the N-terminal ER signal sequence to the C-terminal end prevents ER entry. Since the C-terminus is synthesized last, the Signal-Recognition Particle (SRP) cannot recognize the sequence in time to carry the ribosome to the ER.

  • Soluble ER Proteins (Example: Fuzzy)

    • Soluble proteins in the ER lumen (like Fuzzy) typically have N-terminal signal sequences (not C-terminal).

    • Multiple ribosomes can bind to a single mRNA molecule during translation (polyribosomes).

    • Hydrophobic stop-transfer sequences are present in membrane-inserted proteins but are absent in soluble proteins.

    • Once cleaved, the signal peptide is ejected into the ER membrane and subsequently degraded.

Protein Topology and Translocation Mechanisms

  • ER Lumen vs. Plasma Membrane Proteins

    • Proteins residing in the ER lumen are synthesized by membrane-bound ribosomes.

    • These proteins may eventually be secreted into the extracellular space or reside in other organelles of the endomembrane system.

    • Plasma membrane proteins originate from proteins embedded in the ER membrane, not from the ER lumen.

  • Mechanism of Targeting

    • ER-destined proteins are translated by cytosolic ribosomes and targeted to the ER as soon as the signal sequence emerges during the translation process.

  • Components of ER Transport and Their Locations

    • Signal-Recognition Particle (SRP): Cytosol.

    • SRP Receptor: ER Membrane.

    • Active site of Signal Peptidase: ER Lumen.

    • Protein Translocator: ER Membrane.

    • mRNA: Cytosol.

  • Internal Stop-Transfer Sequences

    • For a protein with an N-terminal signal sequence and an internal stop-transfer sequence, the N-terminus initiates translocation through the channel.

    • When the stop-transfer sequence enters the translocator, the channel discharges both the signal sequence and the stop-transfer sequence sideways into the lipid bilayer.

    • The signal sequence is cleaved, leaving the protein anchored by the hydrophobic stop-transfer sequence as a single-pass transmembrane protein.

  • Competition of Signal Sequences

    • Nuclear Import vs. ER Import: The protein enters the ER because ER targeting is co-translational, whereas nuclear import occurs post-translationally with fully folded proteins.

    • Nuclear Export vs. Mitochondrial Import: The protein enters the mitochondria; for export to work, the protein would have had to enter the nucleus first via an import signal.

    • Mitochondrial Import vs. ER Retention: The protein enters the mitochondria. ER retention requires the protein to enter the ER first; without an ER import signal, the retention signal is never activated.

  • Multi-pass Transmembrane Proteins

    • Deleting an N-terminal signal sequence or mutating its hydrophobic residues to charged residues can cause the next segment to act as an internal start-transfer signal, inverting the protein's orientation.

    • Mutated signal sequences on the cytosolic side are not cleaved because signal peptidase is located only within the ER lumen.

Vesicular Transport and the Secretory Pathway

  • Protein Traversal Pathway

    • Proteins destined for the plasma membrane follow the order: ER Golgi Plasma Membrane.

  • Transport Terminology and Systems

    • Proteins exit the cell via the secretory or exocytic pathways.

    • Fluids and macromolecules enter via the endocytic pathway.

    • Transport vesicles link organelles within the endomembrane system.

  • Vesicle Budding Components (Golgi)

    • Clathrin: Acts at the cytosolic surface to help shape the vesicle; released after budding.

    • Adaptins: Select cargo by capturing cargo receptors that bind specific molecules; they also interact with clathrin.

    • Dynamin: Required for the budding process (pinching off). Absence of dynamin results in the formation of coated pits that cannot mature into vesicles.

  • Directing and Fusing Transport Vesicles

    • Rabs: GTP-binding proteins involved in the recognition and docking of vesicles to target membranes.

    • Tethering Proteins: Initial interaction factors for docking.

    • SNAREs (v-SNARES and t-SNARES): Mediate recognition and catalyze membrane fusion by pulling the vesicle and target membranes together.

    • Adaptins in Targeting: Not involved in targeting; they are removed during uncoating.

  • The Fusion Process

    • Vesicle docking does not always trigger immediate fusion.

    • Fusion requires the displacement of water molecules from the hydrophilic membrane surfaces.

    • GTP hydrolysis by Rab proteins is essential for docking/tethering, but does not provide the direct energy for fusion.

  • SNARE-Mediated Fusion Specifics (Yeast Vacuole Study)

    • Maximal fusion occurs when vesicles carry both v-SNAREs and t-SNAREs.

    • Fusion is possible as long as complementary SNAREs are present between the two vesicles even if one lacks a specific type.

    • Fusion is minimal or fails if both vesicles lack v-SNAREs or both lack t-SNAREs.

Protein Modification and ER Quality Control

  • Glycosylation (N-linked)

    • Oligosaccharides are attached to secreted glycoproteins at the nitrogen atom of the asparagine side chain within the sequence sequence Asn-X-Ser/Thr.

    • A branched 1414-sugar oligosaccharide is added as a single unit, then modified by enzymes in the ER and Golgi before the protein reaches the plasma membrane.

  • Disulfide Bond Formation

    • Occurs in the ER lumen as it is an oxidizing environment.

    • Does not occur in the cytosol because it is a reducing environment.

    • Formed by the oxidation of cysteine side chain pairs, catalyzed by ER lumen enzymes.

    • Stabilizes protein structure.

  • ER Retention and Secretion

    • Proteins with an ER retention signal are captured in the Golgi and returned to the ER.

    • Removal of this signal causes the protein to follow the default secretory pathway toward the extracellular space.

  • ER Quality Control System

    • Chaperone proteins facilitate proper folding and retain misfolded proteins or unassembled complexes within the ER.

    • Misfolded proteins are exported from the ER into the cytosol for degradation (at the proteasome); they are not degraded within the ER lumen.

  • Unfolded Protein Response (UPR)

    • Triggered when sensors in the ER (not the cytoplasm) detect misfolded proteins.

    • Leads to increased production of ER membrane and chaperone proteins.

    • Involves the cytoplasmic activation of gene regulatory proteins to expand the ER's capacity.